Published in Pediatr Infect Dis J on August 01, 1989
Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev (2016) 1.07
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation. Arch Dis Child (1996) 0.83
Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine. CMAJ (1994) 0.75
Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components. J Clin Immunol (1998) 0.75
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med (1996) 4.71
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
The effect of investigator compliance (observer bias) on calculated efficacy in a pertussis vaccine trial. Pediatrics (1998) 2.84
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
Large-quantity production of chicken embryo tracheal organ cultures and use in virus and mycoplasma studies. Appl Microbiol (1970) 2.54
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Pertussis in adults. Ann Intern Med (1998) 2.25
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr (1972) 2.24
Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
A randomized trial of low-air-loss beds for treatment of pressure ulcers. JAMA (1993) 2.16
DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics (1984) 2.15
The 'new' epidemiology of measles and rubella. Hosp Pract (1980) 2.07
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J (1994) 1.90
Why do physicians prescribe antibiotics for children with upper respiratory tract infections? JAMA (1998) 1.89
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis (2000) 1.85
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics (1998) 1.84
A search for Bordetella pertussis infection in university students. Clin Infect Dis (1992) 1.83
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr (1984) 1.81
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics (2001) 1.70
Pertussis in German adults. Clin Infect Dis (1995) 1.68
Evidence assessment of management of acute otitis media: II. Research gaps and priorities for future research. Pediatrics (2001) 1.67
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis (1995) 1.59
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is. JAMA (1990) 1.55
Bacterial-viral interrelations in respiratory infections of children. N Engl J Med (1967) 1.53
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics (1993) 1.49
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
Birth weight and genital mycoplasmas in pregnancy. N Engl J Med (1971) 1.48
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
Erythema migrans after ceftriaxone treatment of aseptic meningitis caused by Borrelia burgdorferi. Pediatr Infect Dis J (2001) 1.43
Acute fever and petechial rash associated with influenza A virus infection. Clin Infect Dis (1999) 1.41
Mycoplasma pneumoniae infections and exanthems. J Pediatr (1975) 1.39
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics (2003) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Household contact study of Bordetella pertussis infections. Clin Infect Dis (1995) 1.35
The evaluation of racemic epinephrine in the treatment of infectious croup. Pediatrics (1973) 1.33
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
Improved method for collection of nasal mucus. J Infect Dis (1977) 1.31
Hemorrhage from cecal ulcers of cytomegalovirus infection: report of a case. Ann Surg (1973) 1.30
Bordetella pertussis infections and sudden unexpected deaths in children. Eur J Pediatr (1996) 1.29
Therapy of Haemophilus influenzae meningitis reconsidered. N Engl J Med (1972) 1.27
Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J (1995) 1.26
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
A prospective search for congenital dermal abnormalities of the craniospinal axis. J Pediatr (1975) 1.23
The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. Bull World Health Organ (2000) 1.23
Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child (1978) 1.22
A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr (1973) 1.21
Influence of parental knowledge and opinions on 12-month diphtheria, tetanus, and pertussis vaccination rates. Am J Dis Child (1988) 1.20
Atypical measles in children previously immunized with attenuated measles virus vaccines. Pediatrics (1972) 1.18
The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J (2000) 1.17
Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr Infect Dis J (1995) 1.17
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Pediatr Infect Dis J (2001) 1.16
Antibodies against measles virus polypeptides in different disease conditions. Infect Immun (1981) 1.16
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis (2000) 1.13
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Congenital contractural arachnodactyly, keratoconus, and probable Marfan syndrome in the same pedigree. J Pediatr (1981) 1.11